Goelzer Investment Management Inc. acquired a new stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 35,321 shares of the company’s stock, valued at approximately $2,379,000. A number of other institutional investors and hedge funds also recently made changes to […] Read this story
